<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100962779</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22269</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Rev Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Rev. Genet.</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-0056</issn>
<issn pub-type="epub">1471-0064</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28804138</article-id>
<article-id pub-id-type="pmc">5935497</article-id>
<article-id pub-id-type="doi">10.1038/nrg.2017.52</article-id>
<article-id pub-id-type="manuscript">NIHMS963647</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Settling the score: variant prioritization and Mendelian disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Eilbeck</surname>
<given-names>Karen</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quinlan</surname>
<given-names>Aaron</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yandell</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Biomedical Informatics, School of Medicine, University of Utah, 421 Wakara Way, Suite 120, Salt Lake City, Utah 84108, USA</aff>
<aff id="A2">
<label>2</label>Department of Human Genetics, Eccles Institute of Human Genetics, School of Medicine, University of Utah, 15 S 2030 E, Salt Lake City, Utah 84112, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence to M.Y. <email>myandell@genetics.utah.edu</email></corresp>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p>These authors contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>Competing interests statement</bold>
</p>
<p>The authors declare competing interests: see Web version for details.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>04</day>
<month>5</month>
<year>2018</year>
</pub-date>
<volume>18</volume>
<issue>10</issue>
<fpage>599</fpage>
<lpage>612</lpage>
<!--elocation-id from pubmed: 10.1038/nrg.2017.52-->
<abstract>
<p id="P1">When investigating Mendelian disease using exome or genome sequencing, distinguishing disease-causing genetic variants from the multitude of candidate variants is a complex, multidimensional task. Many prioritization tools and online interpretation resources exist, and professional organizations have offered clinical guidelines for review and return of prioritization results. In this Review, we describe the strengths and weaknesses of widely used computational approaches, explain their roles in the diagnostic and discovery process and discuss how they can inform (and misinform) expert reviewers. We place variant prioritization in the wider context of gene prioritization, burden testing and genotypeâ€“phenotype association, and we discuss opportunities and challenges introduced by whole-genome sequencing.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>